Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma

By sjmartinez • July 12, 2023

Chehrazi-Raffle A, Leong S, Ali S, Kim T, Melamed S, Li X, Zengin Z, Meza L, Chawla N, Govindarajan A, Castro D, Mercier B, Ebrahimi H, Dizman N, Tripathi N, Sayegh N, Rock A, Yeh J, Pal SK, Onyshchenko M. Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma. Oncologist. 2023 Jul 11:oyad190. doi: 10.1093/oncolo/oyad190. Epub ahead of print. PMID: 37432304.

Tags: General Internal Medicine, Harbor UCLA, Hematology/Oncology, immune checkpoint inhibitors, immunotherapy, Latinx/Latino, Publications, real-world outcomes, renal-cell carcinoma, Social determinants of health

Forearm BMD predicts fracture independently of FRAX

Kanis JA, Johansson H, Harvey NC, Lorentzon M, Cauley JA, Crandall CJ, Huisman M, Khosla S, Kwok T, Mellström D, Orwoll ES, van Schoor NM,[...]

Breaking Barriers to Transplantation: Desensitization with Daratumumab in Peripartum Cardiomyopathy

Okwuosa I, Kumar A, Choi SM, Kamath M, Vellanki S. Breaking Barriers to Transplantation: Desensitization with Daratumumab in Peripartum Cardiomyopathy. Can J Cardiol. 2026 Apr[...]

Mechanical augmentation for vertebral compression fractures: A scoping review

Sen H, Ni AY, Cooper AN, Limerick G, Cardenas-Rojas A, Mahendram S, Osman SK, Radlicz C, Tram J, Teramoto M, Kanjanapanang N, McCormick ZL, Conger[...]